Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Plaque Psoriasis”

87 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 87 results

Large-scale testing (Phase 3)Study completedNCT06088043
What this trial is testing

A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment

Who this might be right for
Plaque Psoriasis
Takeda 693
Testing effectiveness (Phase 2)Ended earlyNCT02243787
What this trial is testing

Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Covagen 24
Large-scale testing (Phase 3)Study completedNCT02886702
What this trial is testing

A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Fougera Pharmaceuticals Inc. 855
Testing effectiveness (Phase 2)Study completedNCT02054481
What this trial is testing

BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab

Who this might be right for
Psoriasis
Boehringer Ingelheim 166
Large-scale testing (Phase 3)Study completedNCT03168256
What this trial is testing

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Can-Fite BioPharma 528
Early research (Phase 1)Study completedNCT03018509
What this trial is testing

Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects

Who this might be right for
Plaque PsoriasisPsoriasisSkin Diseases
Akros Pharma Inc. 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07841314
What this trial is testing

Comparative Study on Unani Formulation Vs Active Control in Plaque Psoriasis

Who this might be right for
Chronic Plaque PsoriasisPlaque PsoriasisPsoriasis+1 more
National Institute of Unani Medicine, Bengaluru 54
Large-scale testing (Phase 3)Study completedNCT01961609
What this trial is testing

Secukinumab in Tumor Necrosis Factor (TNF) - Inadequate Response (IR) Psoriasis Participants.

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 235
Testing effectiveness (Phase 2)Study completedNCT01283698
What this trial is testing

Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis

Who this might be right for
Psoriasis
Almirall, S.A. 20
Large-scale testing (Phase 3)WithdrawnNCT01815723
What this trial is testing

Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Forward-Pharma GmbH
Early research (Phase 1)Looking for participantsNCT05642182
What this trial is testing

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

Who this might be right for
Psoriasis
SFA Therapeutics 90
Early research (Phase 1)Study completedNCT03004339
What this trial is testing

Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test

Who this might be right for
Plaque Psoriasis
DFB Soria, LLC 13
Not applicableStudy completedNCT00705900
What this trial is testing

LCD Solution Versus Calcipotriol Cream in the Treatment of Moderate Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
NeoStrata Company, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT05044234
What this trial is testing

Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
AbbVie 156
Large-scale testing (Phase 3)Active Not RecruitingNCT06220604
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 731
Large-scale testing (Phase 3)Study completedNCT02951533
What this trial is testing

Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag G.m.b.H 119
Testing effectiveness (Phase 2)Study completedNCT02949388
What this trial is testing

Efficacy and Safety of Prurisol Administered Orally for Active Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
Innovation Pharmaceuticals, Inc. 199
Large-scale testing (Phase 3)Study completedNCT01729754
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 1,090
Large-scale testing (Phase 3)Study completedNCT02471144
What this trial is testing

Pediatric Study in Children and Adolescents With Severe Plaque Psoriasis

Who this might be right for
Chronic Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 162
Large-scale testing (Phase 3)WithdrawnNCT01936688
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Who this might be right for
Plaque-type Psoriasis
Sun Pharmaceutical Industries Limited
Next Page